Uninterrupted treatment with novel oral anticoagulants during catheter ablation of atrial fibrillation is safe, suggests new research. Continuation of NOAC therapy was not associated with periprocedural bleeding or thromboembolic complications.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1BMnsXO
No comments:
Post a Comment